TGFβ-induced changes in membrane curvature influence Ras oncoprotein membrane localization.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 08 2022
Historique:
received: 15 05 2022
accepted: 26 07 2022
entrez: 5 8 2022
pubmed: 6 8 2022
medline: 10 8 2022
Statut: epublish

Résumé

In the course of cancer progression tumor cells undergo morphological changes that lead to increased motility and invasiveness thus promoting formation of metastases. This process called epithelial to mesenchymal transition (EMT) is triggered by transforming growth factor (TGFβ) but for gaining the full invasive potential an interplay between signaling of TGFβ and Ras GTPases is required. Ras proteins possess a lipidated domain that mediates Ras association with the plasma membrane, which is essential for Ras biological functions. Type and number of the lipid anchors are the main difference among three Ras variants-H-ras, N-ras and K-ras. The lipid anchors determine membrane partitioning of lipidated proteins into membrane areas of specific physico-chemical properties and curvature. In this study, we investigated the effect of TGFβ treatment on the subcellular localization of H-ras and K-ras. We show that TGFβ increases positive plasma membrane curvature, which is subsequently sensed by H-ras, leading to its elevated plasma membrane localization and activation. This observation suggests the existence of a novel positive feedback loop whereby the increased level of plasma membrane curvature during TGFβ induced EMT attracts more Ras molecules to the plasma membrane resulting in increased Ras activity which in turn promotes further EMT and thus ultimately enables the acquisition of full invasive potential.

Identifiants

pubmed: 35931724
doi: 10.1038/s41598-022-17482-8
pii: 10.1038/s41598-022-17482-8
pmc: PMC9356053
doi:

Substances chimiques

Lipids 0
Oncogene Proteins 0
Transforming Growth Factor beta 0
Transforming Growth Factors 76057-06-2
ras Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13486

Informations de copyright

© 2022. The Author(s).

Références

PLoS One. 2015 Nov 11;10(11):e0142674
pubmed: 26560143
J Cell Biol. 2004 Nov 8;167(3):505-18
pubmed: 15534002
Mol Cell Biol. 2000 Apr;20(7):2475-87
pubmed: 10713171
Cell. 2011 Feb 4;144(3):402-13
pubmed: 21295700
Science. 2008 Jan 11;319(5860):210-3
pubmed: 18187657
Cancer Res. 2012 May 15;72(10):2457-67
pubmed: 22589270
Cell. 2017 Jun 29;170(1):17-33
pubmed: 28666118
Cold Spring Harb Perspect Biol. 2017 Feb 1;9(2):
pubmed: 27864313
PLoS One. 2013 Dec 05;8(12):e80068
pubmed: 24339870
Nat Chem Biol. 2015 Mar;11(3):192-4
pubmed: 25622090
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11875-80
pubmed: 23821745
Cancer. 1999 Feb 1;85(3):554-61
pubmed: 10091729
Nat Chem Biol. 2009 Nov;5(11):835-41
pubmed: 19749743
Nat Rev Drug Discov. 2014 Nov;13(11):828-51
pubmed: 25323927
Nat Rev Mol Cell Biol. 2003 May;4(5):373-84
pubmed: 12728271
Cell Cycle. 2009 Jan 15;8(2):284-98
pubmed: 19177011
Cell. 2017 Jan 12;168(1-2):239-251.e16
pubmed: 28041850
Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):549-54
pubmed: 7549813
Nature. 2001 Jun 28;411(6841):1065-8
pubmed: 11429608
Nat Cell Biol. 1999 Jun;1(2):98-105
pubmed: 10559881
Genes Dev. 1996 Oct 1;10(19):2462-77
pubmed: 8843198
J Cell Biol. 2007 Jul 30;178(3):437-51
pubmed: 17646396
Small GTPases. 2010 Jul;1(1):2-27
pubmed: 21686117
Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10472-6
pubmed: 7479822
J Cell Biol. 2003 Jan 20;160(2):165-70
pubmed: 12527752
Curr Cancer Drug Targets. 2010 Dec;10(8):849-57
pubmed: 20718708
Curr Biol. 2009 Jan 27;19(2):95-107
pubmed: 19150238
Mol Cell Biol. 2015 Nov 16;36(2):363-74
pubmed: 26572827
Mol Cell Biol. 2004 Aug;24(15):6799-810
pubmed: 15254246
Science. 2009 Apr 10;324(5924):208-12
pubmed: 19359578
Life Sci Alliance. 2019 Jul 11;2(4):
pubmed: 31296567
Genes Dev. 2000 Oct 15;14(20):2610-22
pubmed: 11040215
Annu Rev Pathol. 2012;7:423-67
pubmed: 22077552
Sci Rep. 2017 Jan 24;7:41297
pubmed: 28117393
Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1903-7
pubmed: 21245337
Nat Cell Biol. 2001 Apr;3(4):368-75
pubmed: 11283610
Nat Cell Biol. 2012 Aug;14(8):874-81
pubmed: 22750946
Oncogene. 2004 Apr 8;23(15):2672-2680
pubmed: 14755243
Nature. 1985 Aug 22-28;316(6030):701-5
pubmed: 3861940
Oncogene. 2005 Aug 29;24(37):5764-74
pubmed: 16123809
Dev Cell. 2021 Jul 12;56(13):1833-1847
pubmed: 34107299

Auteurs

Alexandros Damalas (A)

Department of Chemistry, University of Copenhagen, Copenhagen, Denmark.
Fourth Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, 1st Rimini St, 12462, Haidari, Athens, Greece.

Ivana Vonkova (I)

Department of Chemistry, University of Copenhagen, Copenhagen, Denmark.
CZ-OPENSCREEN, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 142 20, Prague, Czech Republic.

Marijonas Tutkus (M)

Department of Chemistry, University of Copenhagen, Copenhagen, Denmark.
Institute of Biotechnology, Vilnius University, LT-10257, Vilnius, Lithuania.
Department of Molecular Compounds Physics, Center for Physical Sciences and Technology, LT-02300, Vilnius, Lithuania.

Dimitrios Stamou (D)

Department of Chemistry, University of Copenhagen, Copenhagen, Denmark. stamou@chem.ku.dk.

Articles similaires

Humans RNA, Circular Exosomes Cell Proliferation Epithelial-Mesenchymal Transition
Humans Stomach Neoplasms Macrophages Tumor Microenvironment Disease Progression
Humans Dyrk Kinases Protein Serine-Threonine Kinases Protein-Tyrosine Kinases Epithelial-Mesenchymal Transition
Humans Female Ovarian Neoplasms Cell Proliferation RNA, Long Noncoding

Classifications MeSH